Zura Bio Q4 EPS $(0.49) Misses $(0.22) Estimate

Zura Bio (NASDAQ: ZURA) reported a Q4 loss of $(0.49) per share, missing the analyst consensus estimate of $(0.22) by 122.73%. This represents a 133.33% increase in losses compared to $(0.21) per share from the same period last year.